Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.

Yoshihiro Murakami, Yuji Fujita and Hiroshi Fushiki
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 617;
Yoshihiro Murakami
1Astellas Pharma Inc. Tsukuba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Fujita
1Astellas Pharma Inc. Tsukuba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Fushiki
1Astellas Pharma Inc. Tsukuba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

617

Introduction: Evaluation of fatty acid oxidation is one of the key information for cardiovascular, oncologic, neurologic, and other metabolic diseases. Some SPECT and PET tracers have been developed to measure beta-oxidation, and 18-[18F]fluoro-4-thia-oleate ([18F]FTO) was reported as a PET tracer developed by DeGrado et al. However, the accumulation of radioactivity in bone was also observed by defluorination. In the present study, several analogs of [18F]FTO were synthesized to improve the metabolic stability of C-18F bond, and were preliminarily evaluated in monkey PET studies.

Methods: Three secondary fluorinated analogs, 17-fluoro-4-thia-oleate (17-FTO), 15-fluoro-4-thia-oleate (15-FTO), and 7-fluoro-4-thia-oleate, (7-FTO, AS3504073-00) were designed based on FTO as a lead compound and performed 18F-labeled synthesis. All 18F-labeled compounds were prepared using a two-step synthesis which were (i) a nucleophilic 18F fluorination on a tosylate-precursor, and (ii) a hydrolysis of methylester. Product purification was done by semi-prep HPLC, followed by solid phase extraction eluted with ethanol and saline dilution including ascorbic acid. The obtained 18F-labeled tracers were administered to cynomolgus monkeys and PET measurements were performed.

Results: All three compounds were successfully synthesized with enough quality and stability for animal experiment in a similar manner. In monkey PET studies, 17-[18F]FTO and 15-[18F]FTO were decreased in the bone accumulation, but not changed in the heart in comparison with [18F]FTO. Surprisingly, only [18F]AS3504073-00 showed much more uptake in the heart than that of [18F]FTO and no significant accumulation of radioactivity was observed in the bone. The SUV value of [18F]AS3504073-00 was 8.46, 9.26 and 8.85 in the heart at 20, 60 and 120 min after administration, respectively.

Conclusions: In the present study, we developed a novel PET tracer [18F]AS3504073-00 for beta-oxidation imaging. [18F]AS3504073-00 showed excellent profile as a PET tracer, so that [18F]AS3504073-00 seemed to be one of the best tracers for beta-oxidation imaging. Further evaluations are ongoing.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
Yoshihiro Murakami, Yuji Fujita, Hiroshi Fushiki
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 617;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
Yoshihiro Murakami, Yuji Fujita, Hiroshi Fushiki
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 617;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Predictive modeling of tau aggregation and propagation using PET and DTI
  • Design of calcium-sensing receptor targeted thera(g)nostic agents
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

New Radiotracers

  • Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
  • Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
  • In vitro response of 177Lu-PSMA-617 with two different specific activities
Show more New Radiotracers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire